Surrozen IncDE
For the period ended Jun 30, 2024. Filed Aug 12, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 12, 2024
SRZN$32.64+2.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Unaudited Condensed Consolidated Statements of Operations
Condensed Consolidated Statements of Operations and Comprehensive Loss
(In thousands, except per share amounts)
| Three Months Ended · Six Months Ended | ||||
|---|---|---|---|---|
| June 30, | June 30, | |||
| 2024 | 2023 | 2024 | 2023 | |
| Operating expenses: | ||||
| Research and development | $5,335 | $6,937 | $10,582 | $15,023 |
| General and administrative | 3,714 | 3,338 | 7,597 | 8,637 |
| Restructuring | — | — | — | 1,207 |
| Total operating expenses | 9,049 | 10,275 | 18,179 | 24,867 |
| Loss from operations | (9,049) | (10,275) | (18,179) | (24,867) |
| Interest income | 490 | 623 | 875 | 1,170 |
| Other income, net | 3,695 | 265 | 3,610 | 13 |
| Loss on issuance of common stock, pre-funded warrants and warrants | (20,397) | — | (20,397) | — |
| Net loss | (25,261) | (9,387) | (34,091) | (23,684) |
| Unrealized gain on marketable securities, net of tax | — | 55 | — | 246 |
| Comprehensive loss | $(25,261) | $(9,332) | $(34,091) | $(23,438) |
| Net loss per share attributable to common stockholders, basic and diluted | $(7.99) | $(4.68) | $(13.00) | $(11.84) |
| Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted | 3,162 | 2,004 | 2,622 | 2,001 |
Condensed Consolidated Statements of Stockholders’ Equity
(In thousands)
| Additional · Total | |||||
|---|---|---|---|---|---|
| Common stock · paid-in · Accumulated · stockholders’ | |||||
| Shares | Amount | capital | deficit | equity | |
| Balance at December 31, 2023 | 2,063 | $— | $259,630 | $(221,695) | $37,935 |
| Vesting of restricted stock units | 44 | — | — | — | — |
| Vesting of early exercised stock options | — | — | 1 | — | 1 |
| Stock-based compensation expense | — | — | 1,030 | — | 1,030 |
| Net loss | — | — | — | (8,830) | (8,830) |
| Balance at March 31, 2024 | 2,107 | — | 260,661 | (230,525) | 30,136 |
| Issuance of common stock in the Private Placement | 1,092 | — | — | — | — |
| Issuance of common stock upon employee stock purchase plan | 7 | — | 42 | — | 42 |
| Stock-based compensation expense | — | — | 1,145 | — | 1,145 |
| Net loss | — | — | — | (25,261) | (25,261) |
| Balance at June 30, 2024 | 3,206 | $— | $261,848 | $(255,786) | $6,062 |
| Additional · Accumulatedother · Total | ||||||
|---|---|---|---|---|---|---|
| Common stock · paid-in · comprehensive · Accumulated · stockholders’ | ||||||
| Shares | Amount | capital | loss | deficit | equity | |
| Balance at December 31, 2022 | 2,006 | $— | $254,895 | $(241) | $(178,653) | $76,001 |
| Repurchase of early exercised stock options | (1) | — | — | — | — | — |
| Vesting of early exercised stock options | — | — | 13 | — | — | 13 |
| Stock-based compensation expense | — | — | 1,129 | — | — | 1,129 |
| Other comprehensive gain | — | — | — | 191 | — | 191 |
| Net loss | — | — | — | — | (14,297) | (14,297) |
| Balance at March 31, 2023 | 2,005 | — | 256,037 | (50) | (192,950) | 63,037 |
| Issuance of common stock under employee stock purchase plan | 33 | — | 187 | — | — | 187 |
| Vesting of early exercised stock options | — | — | 8 | — | — | 8 |
| Stock-based compensation expense | — | — | 1,158 | — | — | 1,158 |
| Other comprehensive gain | — | — | — | 55 | — | 55 |
| Net loss | — | — | — | — | (9,387) | (9,387) |
| Balance at June 30, 2023 | 2,038 | $— | $257,390 | $5 | $(202,337) | $55,058 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.